Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 5, 2021
Targeting KRAS in non-small-cell lung cancer: recent progress and new approachesM Reck, D P Carbone, M Garassino, et al.
Critical Reviews in Oncology/Hematology|December 31, 2013
Targeted therapy-induced diarrhea: A review of the literatureM A Pessi, N Zilembo, E R Haspinger, et al.
Respiratory Research|August 27, 2016
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlationsU Peretti, R Ferrara, S Pilotto, et al.
Anticancer Research|November 2, 2010
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter surveyA Mancuso, S Sacchetta, P C Saletti, et al.
Lung Cancer (Amsterdam, Netherlands)|September 23, 2011
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter surveyP A Zucali, M Simonelli, G Michetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.
ESMO Open|June 25, 2025
Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective studyC Catania, S V Liu, M Garassino, et al.
ESMO Open|June 11, 2021
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)F Conforti, M Marino, V Vitolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastasesE E Vokes, N Ready, E Felip, et al.
Pageof 1